Published in Mol Cell Biol on September 01, 1997
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev (1998) 5.60
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol (1997) 4.36
c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J (1999) 3.65
Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY) (2012) 2.59
Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev (2001) 2.56
Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature (2008) 2.32
Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol (2004) 2.27
14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol (1998) 2.07
Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. Cancer Res (2005) 1.93
Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol Biol Cell (1999) 1.73
Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol (1999) 1.58
Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol (2008) 1.56
Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J (2003) 1.55
Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion. Mol Cell Biol (2008) 1.53
Cell senescence and hypermitogenic arrest. EMBO Rep (2003) 1.52
Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol Cell Biol (2005) 1.50
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death Differ (2013) 1.50
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev (2000) 1.47
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol (2003) 1.44
Graded mitogen-activated protein kinase activity precedes switch-like c-Fos induction in mammalian cells. Mol Cell Biol (2005) 1.42
Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol Cell Biol (2000) 1.41
The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol (2000) 1.40
The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol (1999) 1.39
Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Mol Cell Biol (2001) 1.37
Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol Cell Biol (1999) 1.37
Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol (2004) 1.35
Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol (2001) 1.35
Regulation of the Forkhead transcription factor AFX by Ral-dependent phosphorylation of threonines 447 and 451. Mol Cell Biol (2001) 1.34
Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc Natl Acad Sci U S A (2000) 1.32
Biology of human papillomaviruses. Int J Exp Pathol (2001) 1.31
Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol (1999) 1.29
Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth. Mol Cell Biol (1999) 1.27
Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol Cell Biol (1998) 1.26
Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. Cell Stem Cell (2012) 1.24
Functions and mechanisms of receptor tyrosine kinase Torso signaling: lessons from Drosophila embryonic terminal development. Dev Dyn (2005) 1.21
ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol Biol Cell (2007) 1.18
A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040. Neoplasia (2005) 1.18
Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol Cell Biol (1999) 1.17
Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol Cell Biol (1999) 1.16
Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. J Exp Med (2010) 1.15
Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells. Mol Cell Biol (2004) 1.15
Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep (2012) 1.14
Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J Exp Med (2004) 1.13
Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J (1999) 1.11
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem J (2002) 1.11
RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci U S A (2006) 1.10
E7 abolishes raf-induced arrest via mislocalization of p21(Cip1). Mol Cell Biol (2002) 1.09
Distinct functions for ERKs? J Biol (2006) 1.08
A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation. Mol Cell Biol (2003) 1.03
ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation. Clin Exp Metastasis (1999) 1.01
The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence. Mol Cell Biol (2006) 1.01
Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition. Mol Cell Biol (2004) 1.00
Differential requirement for STAT by gain-of-function and wild-type receptor tyrosine kinase Torso in Drosophila. Development (2002) 1.00
p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep (2001) 0.98
Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J (1998) 0.98
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells. J Med Chem (2009) 0.94
Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1. Cell Prolif (2006) 0.94
A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells. Cell Death Dis (2012) 0.94
Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway. Mol Cell Biol (2000) 0.93
Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway. Am J Surg (2009) 0.93
BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications. Oncotarget (2014) 0.92
Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways. Mol Cell Biol (2000) 0.92
Distinct effects of mitogens and the actin cytoskeleton on CREB and pocket protein phosphorylation control the extent and timing of cyclin A promoter activity. Mol Cell Biol (2001) 0.91
Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J Clin Invest (2013) 0.90
Activation of endothelial ras signaling bypasses senescence and causes abnormal vascular morphogenesis. Cancer Res (2010) 0.89
Modeling resistance to pathway-targeted therapy in ovarian cancer. Cell Cycle (2005) 0.88
Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors. Toxicol Appl Pharmacol (2008) 0.87
Drosophila gain-of-function mutant RTK torso triggers ectopic Dpp and STAT signaling. Genetics (2003) 0.87
Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage. Eukaryot Cell (2009) 0.87
Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells. Br J Pharmacol (2002) 0.86
Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells. PLoS One (2013) 0.85
A novel role for farnesyl pyrophosphate synthase in fibroblast growth factor-mediated signal transduction. Biochem J (2002) 0.84
Involvement of protein kinase A in fibroblast growth factor-2-activated transcription. Proc Natl Acad Sci U S A (2000) 0.84
Identification of a potent herbal molecule for the treatment of breast cancer. BMC Cancer (2009) 0.84
Signaling threshold regulation by the Ras effector IMP. J Biol Chem (2008) 0.84
Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells. Mol Biol Cell (1999) 0.83
Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex. Am J Physiol Cell Physiol (2011) 0.83
MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Invest (2015) 0.81
G1/S cell cycle arrest provoked in human T cells by antibody to CD26. Immunology (2002) 0.81
Fitting Boolean networks from steady state perturbation data. Stat Appl Genet Mol Biol (2011) 0.81
Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways. Mol Cell Biol (2000) 0.81
Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation. Genes Cancer (2010) 0.81
HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold. Mol Cell Biol (2014) 0.81
Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells. Evid Based Complement Alternat Med (2015) 0.80
RAF and antioxidants prevent cell death induction after growth factor abrogation through regulation of Bcl-2 proteins. Exp Cell Res (2013) 0.80
Fibroblast growth factor 2 causes G2/M cell cycle arrest in ras-driven tumor cells through a Src-dependent pathway. PLoS One (2013) 0.79
Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery. Oncogene (2012) 0.79
Effects of disulfiram on apoptosis in PANC-1 human pancreatic cancer cell line. Res Pharm Sci (2015) 0.79
Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. Br J Pharmacol (2009) 0.78
Differential regulation of MAP kinase cascade in human colorectal tumorigenesis. Br J Cancer (1999) 0.78
Comparison of the anti-cancer effect of Disulfiram and 5-Aza-CdR on pancreatic cancer cell line PANC-1. Adv Biomed Res (2014) 0.77
ERK and JNK activation is essential for oncogenic transformation by v-Rel. Oncogene (2010) 0.77
Multi-Compartmentalisation in the MAPK Signalling Pathway Contributes to the Emergence of Oscillatory Behaviour and to Ultrasensitivity. PLoS One (2016) 0.77
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling. Oncotarget (2016) 0.77
Threshold-free population analysis identifies larger DRG neurons to respond stronger to NGF stimulation. PLoS One (2012) 0.77
Dynamic Modeling and Analysis of the Cross-Talk between Insulin/AKT and MAPK/ERK Signaling Pathways. PLoS One (2016) 0.76
Atypical role of sprouty in p21 dependent inhibition of cell proliferation in colorectal cancer. Mol Carcinog (2015) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol (1985) 25.52
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 21.15
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Improved retroviral vectors for gene transfer and expression. Biotechniques (1989) 19.48
Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell (1993) 16.91
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell (1995) 12.39
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature (1983) 11.61
Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell (1994) 9.73
Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell (1995) 9.27
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (1995) 8.53
Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol (1992) 7.72
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev (1993) 7.41
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol (1994) 7.40
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell (1992) 7.06
Raf-1 activates MAP kinase-kinase. Nature (1992) 7.05
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature (1994) 6.16
Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science (1993) 6.07
Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol (1996) 5.99
MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev (1994) 5.96
Activation of the MAP kinase pathway by the protein kinase raf. Cell (1992) 5.95
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev (1995) 5.63
Function and regulation of ras. Annu Rev Biochem (1993) 4.69
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev (1995) 4.64
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature (1993) 4.61
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A (1995) 4.54
Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell (1995) 4.48
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol (1997) 4.36
Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell (1990) 4.27
Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol (1993) 4.24
Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature (1991) 4.04
Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J (1992) 4.00
Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature (1991) 3.97
Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J Biol Chem (1991) 3.81
FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell (1993) 3.59
MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol (1995) 3.32
CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev (1996) 3.27
Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol (1993) 3.13
EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol (1994) 3.06
A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways. Cell (1994) 3.04
Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature (1985) 2.82
MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J (1992) 2.71
Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (1986) 2.64
The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev (1996) 2.61
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature (1997) 2.60
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A (1993) 2.55
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol (1995) 2.47
Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene (1994) 2.43
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell (1989) 2.42
Ste12 and Mcm1 regulate cell cycle-dependent transcription of FAR1. Mol Cell Biol (1996) 2.29
Alternative splicing of human cyclin E. J Cell Sci (1994) 2.20
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters. Nature (1986) 2.15
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene (1994) 2.10
The Ras signaling pathway in Drosophila. Curr Opin Genet Dev (1995) 2.07
Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature (1997) 2.03
Xenopus MAP kinase activator is a serine/threonine/tyrosine kinase activated by threonine phosphorylation. EMBO J (1992) 1.98
The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. Nucleic Acids Res (1987) 1.98
Cell determination strategies in the Drosophila eye. Development (1997) 1.95
Regulation of the cell cycle machinery by oncogenic ras. Oncogene (1996) 1.92
PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol (1994) 1.90
Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev (1997) 1.88
Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol (1995) 1.87
Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A (1997) 1.86
Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol (1996) 1.82
Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J (1988) 1.80
B-raf, a new member of the raf family, is activated by DNA rearrangement. Mol Cell Biol (1988) 1.78
A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem (1993) 1.74
Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem (1992) 1.73
Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor. J Cell Biol (1981) 1.72
Two unrelated cell-derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus MH2. EMBO J (1983) 1.67
The sevenless signalling cassette mediates Drosophila EGF receptor function during epidermal development. Development (1994) 1.66
The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc Natl Acad Sci U S A (1993) 1.63
v-mil induces autocrine growth and enhanced tumorigenicity in v-myc-transformed avian macrophages. Cell (1986) 1.52
Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res (1996) 1.46
Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci (1993) 1.46
Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci (1993) 1.45
Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr Biol (1997) 1.41
Threshold responses to the dorsal regulatory gradient and the subdivision of primary tissue territories in the Drosophila embryo. Curr Opin Genet Dev (1996) 1.37
Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene (1997) 1.35
Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell (1995) 1.28
Raf regulates positive selection. Eur J Immunol (1996) 1.21
Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1. Mol Cell Biol (1994) 1.16
Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol (1996) 1.15
v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. Oncogene (1993) 1.10
Induction of transformation and DNA synthesis after microinjection of raf proteins. Mol Cell Biol (1990) 1.08
Effect of nerve growth factor on the expression of cell cycle regulatory proteins in PC12 cells: dissection of the neurotrophic response from the anti-mitogenic response. Oncogene (1996) 1.01
Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene (1996) 0.96
Insulin and insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells. Endocrinology (1988) 0.90
Retroviral gene transfer using safe and efficient packaging cell lines. Ann N Y Acad Sci (1990) 0.90
Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA. J Biol Chem (1995) 0.90
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency. Nucleic Acids Res (1981) 8.10
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res (1990) 4.79
Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell (1993) 4.10
Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol (2002) 3.83
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (1992) 3.43
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol (1986) 2.86
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
An in situ transgenic enzyme marker for the midgestation mouse embryo and the visualization of inner cell mass clones during early organogenesis. Development (1989) 2.55
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature (1982) 2.54
Multiple mRNAs are generated from the chicken lysozyme gene. Cell (1981) 2.46
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell (1989) 2.42
Negative autoregulation of c-myc transcription. EMBO J (1990) 2.38
Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J (1999) 2.31
Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev (1994) 2.29
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A (1990) 1.89
Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev (1997) 1.88
Cell senescence and cancer. Nat Rev Cancer (2001) 1.82
Cloning of chicken lysozyme structural gene sequences synthesized in vitro. Nucleic Acids Res (1978) 1.80
Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J (1988) 1.80
Lack of replicative senescence in normal rodent glia. Science (2001) 1.79
Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science (2001) 1.76
Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene (1992) 1.73
Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res (1993) 1.53
Scrape-loading of Swiss 3T3 cells with ras protein rapidly activates protein kinase C in the absence of phosphoinositide hydrolysis. Oncogene (1989) 1.50
Synthesis of ds-cDNA involving addition of dCMP tails to allow cloning of 5'-terminal m RNA sequences. Methods Enzymol (1983) 1.46
Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol (1990) 1.38
Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene (1997) 1.35
Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature (1983) 1.25
Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci (1994) 1.23
Increasing muscle mass in spinal cord injured persons with a functional electrical stimulation exercise program. Arch Phys Med Rehabil (1999) 1.20
Chicken lysozyme gene contains several intervening sequences. Proc Natl Acad Sci U S A (1979) 1.17
Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene (2001) 1.13
Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res (1996) 1.08
C-MYC: evidence for multiple regulatory functions. Semin Cancer Biol (1990) 1.06
Structure of the lysozyme gene and expression in the oviduct and macrophages. Haematol Blood Transfus (1981) 1.06
Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells. J Cell Biol (1989) 1.05
p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep (2001) 0.98
Isolation and characterization of the chicken ovomucoid gene. Nucleic Acids Res (1979) 0.96
Establishment of rat endometrial cell lines by retroviral mediated transfer of immortalizing and transforming oncogenes. Oncogene (1990) 0.95
Intertissue differences in the hysteretic behaviour of carnitine palmitoyltransferase in the presence of malonyl-CoA. Biochem J (1986) 0.89
Pre-weaning performance and health of pigs born to cloned (fetal cell derived) swine versus non-cloned swine. Theriogenology (2004) 0.88
Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts. Oncogene (1995) 0.85
The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors. Proc Natl Acad Sci U S A (1989) 0.84
The isolation and characterization of the chicken lysozyme and ovomucoid gene. J Steroid Biochem (1980) 0.83
p53: only ARF the story. Nat Cell Biol (2000) 0.82
Signal transduction by p21ras. Int J Cancer Suppl (1989) 0.80
Control of division and differentiation in oligodendrocyte-type-2 astrocyte progenitor cells. Ciba Found Symp (1990) 0.80
Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery. Oncogene (2012) 0.79
Choice and manipulation of retroviral vectors. Methods Mol Biol (1991) 0.79
Messenger RNA activities for two liver enzymes, tyrosine aminotransferase and tryptophan oxygenase, in Morris hepatoma 5123C and 9618A and in HTC cells. Correlation with enzyme activities. Eur J Biochem (1978) 0.78
Prenatal diagnosis of thrombocytopenia absent radius syndrome by ultrasound and cordocentesis. Prenat Diagn (1990) 0.78
Corrected south coast air basin oxidant data: some conclusions and implications. Environ Sci Technol (1976) 0.78
Apparent functional independence of the mitochondrial and nuclear transcription systems in cultured human cells. Mol Gen Genet (1994) 0.77
Differential behavior of two dexamethasone induced mRNA activities in HTC cells in response to cordycepin and to withdrawal of hormone. Biochem Biophys Res Commun (1978) 0.77
Cooperation between cellular oncogenes in the transformation of primary rat embryo fibroblasts. Prog Med Virol (1985) 0.76
Follow-up at a Dutch addiction hospital and effectiveness of therapeutic community treatment. Subst Use Misuse (1998) 0.75
[Induction of primitive neuroectodermal tumors by oncogene complementation]. Verh Dtsch Ges Pathol (1990) 0.75
[The silent myocardial infarct. Remarks on the clinical diagnosis of the infarct]. Landarzt (1967) 0.75
Biculturality and homosexuality. Soc Work (1990) 0.75
Reactivity-based hydrocarbon controls: scientific issues and potential regulatory applications. J Air Waste Manage Assoc (1992) 0.75
[Immunosuppressive treatment of progressive chronic polyarthritis]. Z Gesamte Inn Med (1975) 0.75
[Use and process evaluation of a self control program in enuresis diurna]. Prax Kinderpsychol Kinderpsychiatr (1983) 0.75
In vitro synthesis and stability of RNA in isolated nuclei from bovine lymphocytes. Biochem Biophys Res Commun (1977) 0.75
Activated oncogenes in Burkitt's lymphoma. Curr Top Microbiol Immunol (1984) 0.75
Poverty and welfare policies. Proc Nutr Soc (1974) 0.75